Predicting Survival in Glioblastoma Patients Using Diffusion MR Imaging Metrics—A Systematic Review

Despite advances in surgical and medical treatment of glioblastoma (GBM), the medium survival is about 15 months and varies significantly, with occasional longer survivors and individuals whose tumours show a significant response to therapy with respect to others. Diffusion MRI can provide a quantit...

Full description

Bibliographic Details
Main Authors: Valentina Brancato, Silvia Nuzzo, Liberatore Tramontano, Gerolama Condorelli, Marco Salvatore, Carlo Cavaliere
Format: Article
Language:English
Published: MDPI AG 2020-10-01
Series:Cancers
Subjects:
DWI
DTI
Online Access:https://www.mdpi.com/2072-6694/12/10/2858

Similar Items